Stock listing
H7T1 Stock Price, News, Filings & Events — Hutchmed (china) Limited
Selected listing: H7T1 · DUS · EUR · DE
This page tracks Hutchmed (china) Limited's H7T1:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following H7T1:DUS. H7T1:DUS is the stock-level entry point for investors researching Hutchmed (china) Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- H7T1:DUS
- Asset type
- Stock
- Market cap
- $2.42B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- DUS
- Currency
- EUR
Hutchmed (china) Limited H7T1:DUS stock context
This page tracks Hutchmed (china) Limited's H7T1:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following H7T1:DUS. H7T1:DUS is the stock-level entry point for investors researching Hutchmed (china) Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Hutchmed (china) Limited
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
September 3, 2026
HUTCHMED Reports 2026 Interim Results
July 30, 2026
HUTCHMED to Announce 2026 Half-Year Financial Results
June 30, 2026
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
May 21, 2026
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
April 29, 2026
Hutchmed (china) Limited earnings calls
HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q3 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call
March 19, 2025 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q2 2024 Earnings Call
July 31, 2024 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2023 Earnings Call
February 28, 2024 · Replay with transcript and chapters
Research Hutchmed (china) Limited
Hutchmed (china) Limited investor report
Review AI stock analysis and investor report context for H7T1:DUS.
Hutchmed (china) Limited company profile
View the public company page for Hutchmed (china) Limited on 6ix.
Hutchmed (china) Limited news
Read company news and market updates connected to Hutchmed (china) Limited.
Hutchmed (china) Limited investor events
Find investor webinars, events, and replay context for Hutchmed (china) Limited.
Alternate listings
13:HKEX
HK · HKD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HCM:NASDAQ
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HCM:LSE
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
H7T2:GETTEX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
A2PJ5B:LSX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HCM:BOATS
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
A2PJ5B:LS
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HMDCF:OTC
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
0J7G:LSE
GB · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HCML:AQUISUK
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
H7T1:GETTEX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.
HCM.GB:AQUIS
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is H7T1:DUS.